We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close
Focus On
In-House Counsel | Insurance | Intellectual Property | Immigration | Natural Resources | Real Estate | Tax
Story image

Issues when measuring drug toxicity

Tuesday, March 19, 2019 @ 10:54 AM | By Esther Carenza

This column is the corollary to my earlier story: Problems with measuring drug toxicity.

An important issue which arises from the biological samples taken by a drug recognition expert (DRE) involves...